Therapeutic Outcomes of Endoscopic Submucosal Dissection for Superficial Squamous Cell Carcinoma in the Remnant Esophagus After Subtotal Esophagectomy
Journal of Gastroenterology and Hepatology · 2026
DOI: 10.1111/jgh.70175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Yoshiaki Ando und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan. Hauptthemen laut MEDLINE: Esophagectomy, Endoscopic Mucosal Resection, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background and Aim Limited reports exist on the treatment outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in the remnant esophagus after subtotal esophagectomy. Therefore, we aimed to investigate the feasibility and efficacy of endoscopic submucosal dissection in such cases.
Methods
We identified consecutive patients who underwent endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in the remnant esophagus after subtotal esophagectomy between January 2010 and June 2024 from a prospectively maintained database and retrospectively evaluated the short‐ and long‐term outcomes.
Results
A total of 43 consecutive patients with 49 lesions were included in this study. All lesions, including 15 involving the anastomotic site, were resected en bloc with tumor‐free vertical margins. The median resection time was 40 min. No perforations, delayed bleeding, or aspiration pneumonia were observed. The median lesion size was 15 mm with most being intramucosal cancer (97%, 48/49). Post‐ESD stricture occurred in three patients (6%). In univariate analysis, larger lesion size and greater circumferential extent were significantly associated with longer resection time (≥ 90 min). Lesions involving the anastomotic site were not significantly associated with longer resection times. No local recurrence was observed during a median follow‐up period of 3 years. The 3‐year overall survival and disease‐specific survival rates were 89% and 100%, respectively.
Conclusions
Endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in the remnant esophagus after subtotal esophagectomy is technically feasible and effective, with favorable long‐term outcomes. It might present a reasonable treatment option for such cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan.
ORCID-Profile: Yoshiaki Ando, Yasuhiro Tani, Tomoya Ueda, Shunsuke Yoshii, Takashi Kanesaka, Noriya Uedo
Zitieren
APA
Ando, Y., Kato, M., Tani, Y., Ueda, T., Tanabe, G., Fujimoto, Y., Ito, N., Tsukuda, N., Matsuyama, K., Morita, M., Yoshii, S., Shichijo, S., Kanesaka, T., Yamamoto, S., Higashino, K., Uedo, N., Michida, T., & Ishihara, R. (2026). Therapeutic Outcomes of Endoscopic Submucosal Dissection for Superficial Squamous Cell Carcinoma in the Remnant Esophagus After Subtotal Esophagectomy. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70175
Vancouver
Ando Y, Kato M, Tani Y, Ueda T, Tanabe G, Fujimoto Y, et al. Therapeutic Outcomes of Endoscopic Submucosal Dissection for Superficial Squamous Cell Carcinoma in the Remnant Esophagus After Subtotal Esophagectomy. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70175
BibTeX
@article{Ando2026,
author = {Ando, Yoshiaki and Kato, Minoru and Tani, Yasuhiro and Ueda, Tomoya and Tanabe, Gentaro and Fujimoto, Yuta and Ito, Noriaki and Tsukuda, Nobutoshi and Matsuyama, Kazuki and Morita, Muneshin and Yoshii, Shunsuke and Shichijo, Satoki and Kanesaka, Takashi and Yamamoto, Sachiko and Higashino, Koji and Uedo, Noriya and Michida, Tomoki and Ishihara, Ryu},
title = {Therapeutic Outcomes of Endoscopic Submucosal Dissection for Superficial Squamous Cell Carcinoma in the Remnant Esophagus After Subtotal Esophagectomy},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
doi = {10.1111/jgh.70175}
}
EUVIMED